FDA 483 - Lernapharm (Loris) Inc. - May 06, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Lernapharm Inc. in Saint-Laurent was inspected by the FDA from April 28 to May 6, 2022, resulting in two observations. The inspection revealed issues with the evaluation of labeling reconciliation discrepancies and deficiencies in laboratory controls, including inadequate sterility testing conditions and incomplete software validation for critical analytical systems. These findings indicate significant concerns regarding the firm's quality control and data integrity practices.
ID · 6ff19092-9421-4ba8-a462-f91cae9427d1